76 related articles for article (PubMed ID: 17461768)
1. DNA-enzyme-mediated cleavage of human immunodeficiency virus type 1 Gag RNA is significantly augmented by antisense-DNA molecules targeted to hybridize close to the cleavage site.
Sood V; Gupta N; Bano AS; Banerjea AC
Oligonucleotides; 2007; 17(1):113-21. PubMed ID: 17461768
[TBL] [Abstract][Full Text] [Related]
2. In vitro-selected RNA cleaving DNA enzymes from a combinatorial library are potent inhibitors of HIV-1 gene expression.
Sriram B; Banerjea AC
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):667-73. PubMed ID: 11104672
[TBL] [Abstract][Full Text] [Related]
3. In vitro selected RNA-cleaving DNA enzymes from combinatorial libraries.
Chakraborti S; Sriram B; Banerjea AC
Methods Mol Biol; 2004; 252():279-90. PubMed ID: 15017057
[TBL] [Abstract][Full Text] [Related]
4. Identification of cleavage sites in the HIV-1 TAR RNA by 10-23 and 8-17 catalytic motif containing DNA enzymes.
Chakraborti S; Banerjea AC
Biomacromolecules; 2003; 4(3):568-71. PubMed ID: 12741771
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 VprB and C RNA cleavage by potent 10-23 DNAzymes that also cause reversal of G2 cell cycle arrest mediated by Vpr genes.
Bano AS; Gupta N; Sharma Y; Sood V; Banerjea AC
Oligonucleotides; 2007; 17(4):465-72. PubMed ID: 18078383
[TBL] [Abstract][Full Text] [Related]
6. Nucleic acid-mediated cleavage of M1 gene of influenza A virus is significantly augmented by antisense molecules targeted to hybridize close to the cleavage site.
Kumar B; Khanna M; Kumar P; Sood V; Vyas R; Banerjea AC
Mol Biotechnol; 2012 May; 51(1):27-36. PubMed ID: 21744034
[TBL] [Abstract][Full Text] [Related]
7. Potent knock down of HIV-1 replication by targeting HIV-1 Tat/Rev RNA sequences synergistically with catalytic RNA and DNA.
Sood V; Unwalla H; Gupta N; Chakraborti S; Banerjea AC
AIDS; 2007 Jan; 21(1):31-40. PubMed ID: 17148965
[TBL] [Abstract][Full Text] [Related]
8. Sequence-specific cleavage activities of DNA enzymes targeted against HIV-1 Gag and Nef regions.
Dash BC; Banerjea AC
Oligonucleotides; 2004; 14(1):41-7. PubMed ID: 15104895
[TBL] [Abstract][Full Text] [Related]
9. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.
Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC
Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 gene expression by novel DNA enzymes targeted to cleave HIV-1 TAR RNA: potential effectiveness against all HIV-1 isolates.
Chakraborti S; Banerjea AC
Mol Ther; 2003 Jun; 7(6):817-26. PubMed ID: 12788656
[TBL] [Abstract][Full Text] [Related]
11. Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA.
Koppelhus U; Zachar V; Nielsen PE; Liu X; Eugen-Olsen J; Ebbesen P
Nucleic Acids Res; 1997 Jun; 25(11):2167-73. PubMed ID: 9153317
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of cleavage of human immunodeficiency virus type-1 (HIV-1) RNAs.
Takahashi H; Sawa H; Hasegawa H; Sata T; Hall WW; Nagashima K; Kurata T
Biochem Biophys Res Commun; 2002 May; 293(3):1084-91. PubMed ID: 12051771
[TBL] [Abstract][Full Text] [Related]
13. Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.
't Hoen PA; Out R; Commandeur JN; Vermeulen NP; van Batenburg FH; Manoharan M; van Berkel TJ; Biessen EA; Bijsterbosch MK
RNA; 2002 Dec; 8(12):1572-83. PubMed ID: 12515389
[TBL] [Abstract][Full Text] [Related]
14. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
Gao HQ; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
[TBL] [Abstract][Full Text] [Related]
15. Antisense activity detection by inhibition of fluorescence resonance energy transfer.
Benítez-Hess ML; DiPaolo JA; Alvarez-Salas LM
Luminescence; 2004; 19(2):85-93. PubMed ID: 15098208
[TBL] [Abstract][Full Text] [Related]
16. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of infectious human immunodeficiency virus type 1 virions via lentiviral vector encoded short antisense RNAs.
Gu S; Ji J; Kim JD; Yee JK; Rossi JJ
Oligonucleotides; 2006; 16(4):287-95. PubMed ID: 17155905
[TBL] [Abstract][Full Text] [Related]
18. Endoribonucleolytic cleavage of RNA: oligodeoxynucleotide hybrids by the ribonuclease H activity of HIV-1 reverse transcriptase.
Dudding LR; Harington A; Mizrahi V
Biochem Biophys Res Commun; 1990 Feb; 167(1):244-50. PubMed ID: 1690003
[TBL] [Abstract][Full Text] [Related]
19. Gaining target access for deoxyribozymes.
Schubert S; Fürste JP; Werk D; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
J Mol Biol; 2004 May; 339(2):355-63. PubMed ID: 15136038
[TBL] [Abstract][Full Text] [Related]
20. Sequence-specific cleavage of BM2 gene transcript of influenza B virus by 10-23 catalytic motif containing DNA enzymes significantly inhibits viral RNA translation and replication.
Kumar B; Kumar P; Rajput R; Saxena L; Daga MK; Khanna M
Nucleic Acid Ther; 2013 Oct; 23(5):355-62. PubMed ID: 23971908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]